Report No. 36A print friendly version of this report is available as a PDF (266 KB)
Week ending 10 September 2010
The Department of Health and Ageing acknowledges the providers of the many sources of data used in this report and greatly appreciates their contribution.
Key IndicatorsInfluenza activity and severity in the community is monitored using the following indicators and surveillance systems:
|Is the situation changing?||Indicated by trends in:
|How severe is the disease, and is severity changing?||Indicated by trends in:
|Is the virus changing?||Indicated by trends in:
- Levels of influenza-like illness (ILI) in the community have continued to increase through most surveillance systems this reporting period with sporadic and widespread activity reported within jurisdictions. However, there was a decline in the number of laboratory confirmed notifications compared to previous weeks.
- There were 267 laboratory confirmed notifications of influenza during this reporting period, including 149 pandemic (H1N1) 2009 cases. This is a substantial decrease in the number of laboratory confirmed notifications compared to the previous week of 501. Notifications of laboratory confirmed influenza were highest in QLD this reporting period and in SA the notification rate over the past month has also been relatively high.
- Results from sentinel laboratory surveillance systems for this reporting period show that 16% of the respiratory tests conducted over this period were positive for influenza, which is a slight decrease from the last reporting period (19%). In 2010, a total of 754 specimens have been positive for influenza (of 10,834 specimens tested), of which 70% were pandemic (H1N1) 2009, 12% were A/H3N2 and 16% were influenza B.
- Up to 10 September 2010, there have been 4,687 confirmed cases of influenza diagnosed in 2010. A total of 39,899 confirmed cases of pandemic (H1N1) 2009 have occurred in Australia since May 2009.
- Sentinel hospitals have continued to report increases in the number of influenza associated hospitalisations, with 24 admissions during the reporting period, including 17 for pandemic (H1N1) 2009. ANZICS reported seven ICU admissions for influenza and the APSU has reported one case of influenza complications in children aged less than 15 years this reporting period.
- The WHO has advised that the world is no longer in phase 6 of influenza pandemic alert, and will now move into the post pandemic period. As at 1 August 2010, over 18,449 deaths worldwide have been reported associated with the pandemic virus. The WHO is currently reporting that influenza transmission is currently most intense in the temperate areas of the Southern Hemisphere, including Australia, New Zealand and Chile, and regions in southern Asia.
1. Influenza activity in Australia
Geographic spread of influenza and ILI – Jurisdictional SurveillanceIn the fortnight ending 3 September, influenza and ILI activity as reported by state and territory Health Departments indicated that there was ‘sporadic’ activity in TAS, ‘local’ activity in the ACT, ‘regional’ activity in NT, QLD and NSW and ‘widespread’ activity in SA, WA and Vic (Figure 1). Definitions of these activity levels are provided in the Data Considerations section of this report.
Figure 1. Map of influenza and ILI activity, by state and territory, during fortnight ending 3 September 2010
Sentinel General Practice SurveillanceIn the week ending 5 September 2010,the national ILI consultation rate to sentinel GPs was approximately 15 cases per 1,000 consultations (Figure 2), an increase from the previous week. Although the rate in 2010 has had a slight upward trend since the beginning of the year, the consultation rate remains below the rate experienced at this time in 2007 and 2008.
Figure 2. Weekly rate of ILI reported from GP ILI surveillance systems from 1 January 2007 to 5 September 2010*
* Delays in the reporting of data may cause data to change retrospectively. As data from the VIDRL surveillance system is combined with ASPREN data for 2010, rates may not be directly comparable across 2007, 2008 and 2009.
SOURCE: ASPREN, and VIDRL GP surveillance system.
Top of Page
Of the ASPREN ILI consultations where a specimen was collected in the week ending 10 September 2010, 25% were positive for influenza, of which the majority of these specimens were pandemic (H1N1) 2009 (17/23)(Table 1). Please note the results of ASPREN ILI laboratory respiratory viral tests does not currently include WA.
Table 1. ASPREN ILI consultations laboratory respiratory viral tests that were positive for influenza for the week ending 10 September 2010.
|ASPREN – national|
|Total specimens tested||93|
|Positive Influenza A||22|
|Pandemic (H1N1) 2009||17|
|Influenza A untyped||5|
|Positive Influenza B||1|
|The most common respiratory virus detected||Influenza|
WA Emergency DepartmentsRespiratory viral presentations reported in Western Australian EDs have continued to increase in recent weeks, which is part of an overall upward trend has been observed since the beginning of 2010 (Figure 3). In the week ending 5 September 2010 there were 610 respiratory viral presentations, including 36 admissions, an increase from 461 presentations in the previous reporting week.
Figure 3. Number of respiratory viral presentations to Western Australia EDs from 1 January 2007 to 5 September 2010 by week
Source: WA ‘Virus Watch’ Report
NSW Emergency DepartmentsIn the week ending 3 September 2010, ILI presentations to NSW EDs remained low and stable (Figure 4). In August 2010, there were 236 presentations with influenza-like illness, a rate of 1.7 per 1,000 presentations, with 19 admissions to hospital following presentation to emergency departments with ILI. This is similar to the previous month and the count of presentations is significantly lower than in August 2009, but similar to the same periods in 2005-2008.
Figure 4: ILI presentations to NSW EDs from 2007-2010, by week
Source: NSW Health ‘Influenza Weekly Epidemiology Report
Top of Page
Flutracking, a national online system for collecting data on ILI in the community, reported that in the week ending 12 September 2010, ILI activity levels appeared to be decreasing across Australia. Fever and cough continued to be reported at a slightly higher rate amongst unvaccinated participants (3.5% compared to 2.9% in vaccinated participants) (Figure 5).
Figure 5. Rate of ILI symptoms among Flutracking participants by week, from week ending 30 May 2010 to week ending 12 September 2010
Source: Flutracking Interim Weekly Report
National Health Call Centre NetworkThe number of calls to the National Health Call Centre Network (NHCCN) in this reporting period was slightly lower than in previous reporting periods (Figure 6). However the percentage of total calls continued to remain stable, and only slightly above levels seen in 2009
Call numbers cannot be compared between early 2009 and early 2010 as not all call centres were online in early 2009. The difference in operating call centre numbers accounts for this apparent increase in recorded ILI calls (and baseline levels) between the two years.
Figure 6. Number of calls to the NHCCN related to ILI and percentage of total calls, Australia, 1 January 2009 to 10 September 2010
Note: national data does not include QLD and VIC
Source: NHCCN data
Top of Page
AbsenteeismIn the week ending 14 July 2010, absenteeism increased to 1.1% (Figure 7). Overall there has been a gradual increasing trend since the beginning of 2010. Please note, due to system changes, this data has not been updated for seven weeks.
Figure 7. Rates of absenteeism (greater than 3 days absent on sick leave), national employer, from 28 January 2007 to 14 July 2010, by week
SOURCE: Absenteeism data
Laboratory confirmed influenza
Sentinel Laboratory SurveillanceResults from sentinel laboratory surveillance systems for this reporting period show that 16% (125/767) of the respiratory tests conducted over this period were positive for influenza, which is a decrease compared to the last reporting period (19%) (Figure 8).
Figure 8. Total number of specimens tested by sentinel laboratories, and proportion positive, 1 January 2010 to 10 September 2010, by week
SOURCE: Sentinel laboratory data from ASPREN, NSW NIC, WA NIC, VIC NIC & TAS Labs
Sentinel laboratories reported 125 specimens positive for influenza during this reporting period, of which 93 were pandemic (H1N1) 2009, 4 were A/H3N2 and 28 were influenza B (Table 1).
Table 2. Laboratory respiratory tests that tested positive for influenza
|NSW NIC||WA NIC||NT|
(reported by WA NIC)
|Total specimens tested||132||344||n/a||222||69|
|Positive Influenza A||4||48||0||34||11|
|Pandemic (H1N1) 2009||4||45||0||34||10|
|Influenza A untyped||0||0||0||0||0|
|Positive Influenza B||0||27||0||0||1|
|The most common respiratory virus detected||RSV and Rhinovirus and hMPV||RSV||n/a||Picornavirus||N/A|
In 2010, a total of 754 specimens have been positive for influenza (7% of 10,834 specimens tested), of which 70% were pandemic (H1N1) 2009 and 11% were A/H3N2 and 16% were influenza B (Figure 9). Sentinel laboratory data are used in addition to National Notifiable Diseases Surveillance System (NNDSS) data to understand the strains circulating in Australia, as approximately 42% of NNDSS notifications are reported as influenza A untyped.
Figure 9. Percentage of specimens tested by sentinel laboratories influenza positive, 1 January 2010 to 10 September 2010, by subtype
SOURCE: Sentinel laboratory data from ASPREN, NSW NIC, WA NIC, VIC NIC & TAS Labs
Top of Page
Laboratory Confirmed Cases Notified to Health DepartmentsDuring this reporting period there was a substantial decline in the number of laboratory confirmed cases of influenza with 267 notifications reported to NNDSS (158 in Qld, 35 in SA, 23 in WA, 18 in Vic, 16 in NSW, 6 in the ACT and TAS, and 5 in the NT). They included 149 cases of pandemic (H1N1) 2009, 89 of influenza A (untyped), 3 cases of influenza A/H3N2, 22 of influenza B, and 4 untyped. The decline in notifications seen in this reporting period will need to be confirmed in coming weeks.
There have been 4,687 confirmed cases of influenza of all types diagnosed during 2010 up to 10 September (Figure 10). Of these, 2,263 (48%) have been sub-typed as pandemic (H1N1) 2009, 1,948 (42%) as influenza type A untyped, 96 (2%) as A/H3N2 and 10 (<1%) as type A&B. A further 308 (7%) have been characterised as influenza type B, and 62 (1%) were untyped.
Figure 10. Laboratory confirmed cases of influenza in Australia, 1 January 2005 to 10 September 2010
Source: NetEpi (2009; NSW 2010) and NNDSS (2010)
Note: The scale in this figure has been limited to 1600 notifications per week to allow for comparison
between 2010 and previous years. In 2009, notifications peaked at approximately 8,300 in Week 30.
In 2010 up to 10 September, the number of laboratory confirmed cases of influenza was 1,408 in QLD, 664 in NSW, 909 in VIC, 644 in WA and 870 in SA. There were a further 86 cases in the NT, 60 in the ACT and 46 cases in TAS (Figure 11).
Figure 11. Laboratory confirmed cases of influenza in Australia, 1 January to 10 September 2010, by state, by week.
In 2010, the distribution of influenza notifications is relatively consistent across all age groups with an overall slight downward trend with increasing age. This distribution is reasonably similar to 2008 except in the 0-4 and the 74 and over age groups where sharp increases are seen (Figure 12). In 2009 the distribution of influenza notifications tended to occur in persons aged less than 55 years, with substantially higher rates observed in persons aged less than 30 years, compared to older age groups.
Figure 12. Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia, 1 January 2008 to 10 September 2010, by age group
Source: NNDSS and NetEpi (NSW).
Top of Page
2. Influenza severity to 3 September 20101
Pandemic (H1N1) 2009While pandemic (H1N1) 2009 is generally considered a mild disease at the community level, it has had serious consequences for some who experience it. Figures of hospitalisations, ICU admissions and deaths are currently used as indicators of the severity of the disease in Australia (Table 2).
Pandemic (H1N1) data for 2009 are currently being finalised through cleaning and validation processes. It is possible that these processes will result in some changes in the data presented here. Validated data will be progressively reported as these steps are completed.
Since the first case of pandemic (H1N1) 2009 in Australia in May 2009, there have been a total of 39,899 confirmed cases of pandemic (H1N1) 2009 in Australia as at 10 September 2010. Of these, 37,636 cases were reported in 2009 and 2,263 cases were reported in 2010. A total of 203 pandemic influenza-associated deaths have been reported, with 12 deaths occurring in 2010.
Table 3. Summary of severity indicators of pandemic (H1N1) in Australia, 2009 and 2010 (up to 10 September 2010)
(H1N1) 2009 cases
|Hospitalised cases||ICU cases||Deaths||Confirmed (H1N1) 2010 cases||Deaths|
|Total number||37,636||13% (4,992/37,636) confirmed cases)||14% |
|Crude rate per 100,000 population||172.1||22.8||3.1||0.9||10.3||n/a|
|Median age (years)||21||31||44||53||24||50|
|Females||51% (19,139/37,636)||51% (2,528/4,992)||53% |
|Vulnerable groups (Indigenous persons, pregnant women & individuals with at least 1 co-morbidity)||n/a||58% (2,892/4,992)||74% |
|Indigenous people~||11% (3,877/34,750)||20% |
(287/1,056 hospitalised females aged
(47/289) hospitalised pregnant women)
|Cases with at least 1 co-morbidity||n/a||46% (2,303/4,992)||67%|
# Data are extracted from a number of sources depending on the availability of information. Figures used in the analysis have been provided in parentheses. Data are not always complete for each summarised figure.
a Data for 2009 from NetEpi, data for 2010 from NNDSS and NetEpi (NSW).
b The number of deaths is most likely under-reported and representative of hospital related death notifications only.
n/a - No data collected or available.
~ The denominator for this row is the number of confirmed cases for which Indigenous status is known. In 2010, 1218 cases had Indigenous status unknown.
* Includes women in the post-partum period.
Top of Page
1 Note that while the analysis of severity is on-going, updates are presented as required when there are significant changes detected. With the current low levels of pandemic (H1N1) 2009 influenza activity in Australia it is anticipated that the indicators of pandemic associated severity will not vary significantly.
Top of Page
Influenza Complications Alert Network (FluCAN)The Influenza Complications Alert Network (FluCAN) continues to report an increase in the number of influenza associated hospitalisations with 17 pandemic (H1N1) 2009 hospitalisations reported, six influenza A (not subtyped) hospitalisations and one influenza B hospitalisation from sentinel hospitals in the week ending 10 September 2010. For the period of 1 March to 10 September 2010, FluCAN has reported a total of 154 influenza associated hospitalisations (Figure 12). Of these hospitalisations, 119 have been associated with pandemic (H1N1) 2009, including 34 with ICU admission.
Figure 13. Number of influenza hospitalisations, sentinel hospitals, Australia, 1 March to 10 September 2010
Source: Influenza Complications Alert Network (FluCAN). Data from 14 sentinel hospitals from all jurisdictions.
Table 4. FluCAN sentinel hospitalisation severity indicator summary 1 March to 10 September 2010
| ||Pandemic (H1N1) 2009||Seasonal||Total Influenza|
|All hospitalised||ICU cases||Deaths||All hospitalised||ICU cases||Deaths ||All hospitalised||ICU cases||Deaths|
|ICU proportion of all hospitilised||27%||20%||25%|
|Median age (years)||31||37||41||41||54||0||34||37||41|
|Total of vulnerable groups (Indigenous, pregnant & individuals with at least 1 co-morbidity)||71%||81%||100%||69%||100%||0%||109||33||2|
|% of all admission|
|% of women of child bearing age (15-49years)||26%||44%||0%||10%||0%||0%||23%||44%||0%|
|Cases with at least 1 co-morbidity||66%||81%||100%||66%||100%||0%||66%||84%||100%|
Australian Paediatric Surveillance Unit (APSU)A survey of admissions of children aged 15 years and under to Intensive Care Units (ICUs) around Australia following complications due to influenza infection is conducted through the Australian Paediatric Surveillance Unit (APSU). Details of admissions are reported on a weekly basis.
For the week ending 12 September 2010, there was one case of severe influenza complication in a child reported to the APSU This is a substantial decline compared to the previous reporting week where there were nine cases reported. Since 1 July 2010, 15 cases of hospitalisations related to severe influenza complications have been reported in children aged 15 years and under. Nine cases have been associated with pandemic (H1N1) 2009, of which two were admitted to ICU. Three cases were associated with Influenza A (not further subtyped), and one case was associated with influenza B. Two of the cases associated with pandemic (H1N1) 2009 had an underlying chronic condition.
Intensive care admissionsThe Australian and New Zealand Intensive Care Society (ANZICS) has reported a total of 93 ICU admissions for influenza in 2010, seven of which occurred during this reporting period. Of these ICU admissions, 64 have been associated with pandemic (H1N1) 2009, 11 with influenza A (not subtyped), 2 with seasonal A/H3N2, 14 with seasonal H1N1 (these may be pandemic cases, yet to be confirmed) and 2 with influenza not typed (Figure 14).
Of the 64 pandemic (H1N1) 2009 ICU admissions in 2010, 49 had known co-morbidities and the median age at admission was 42 years (range 2-80).
Figure 14. Number of ICU admissions for influenza, ANZICS, Australia, 1 January to 10 September 2010
Source: Australian and New Zealand Intensive Care Society (ANZICS) data base
Deaths associated with influenza and pneumonia
Nationally reported pandemic (H1N1) 2009 deathsIn 2010, twelve pandemic influenza related deaths have been notified to the NNDSS. The deaths occurred in late May, July, August and September, with a median age of 50 years. Eleven of the deaths were reported as having underlying risk factors.
Top of Page
NSWDeath registration data show that for the week ending 20 August 2010, there were 128 pneumonia or influenza associated deaths per 1,000 deaths in NSW, which is below the seasonal threshold for this period of 145 per 1,000 deaths (Figure 15).
NSW death registration data cross-matched with laboratory cases of influenza show 13 people with laboratory confirmed influenza have died up to 27 August 2010. All 13 cases had multiple comorbidities and were aged 50 years and over1
Figure 15. Rate of deaths classified as influenza and pneumonia from the NSW Registered Death Certificates, 2005 to 20 August 2010
Source: NSW ‘Influenza Monthly Epidemiology Report’
Typing and antigenic characterisation - WHO Collaborating Centre for Reference & Research on Influenza (WHO CC) in MelbourneFrom 1 January to 12 September 2010, there were 547 Australian influenza isolates subtyped by the WHO CC (Table 3).
Table 5. Typing of influenza isolates from the WHO Collaborating Centre, from 1 January 2010 to 12 September 2010
|Pandemic (H1N1) 2009||16||23||66||111||77||1||135||70||499|
SOURCE: WHO CC
Please note: There may be up to a month delay on reporting of samples.
Isolates tested by the WHO CC are not necessarily a random sample of all those in the community, hence proportions of pandemic (H1N1) 2009 to seasonal are not representative of the proportions circulating.
Antigenic characterisation of 254 pandemic (H1N1) 2009 isolates has shown 230 to be the A/California/7/2009-like strain and one a low reactor version of this strain. Antigenic characterisation of 20 type A/H3N2 isolates has shown 13 to be the A/Perth/16/2009-like and 7 to be the A/Perth/16/2009-like low reactor versions of the strain. One isolate was antigenically characterised as a low-reactor version of B/Florida/4/2006-like and two were characterised as B/Brisbane/60/2008-like.
Antiviral ResistanceThe WHO Collaborating Centre in Melbourne has reported that from 1 January 2010 to 12 September 2010, no isolates (out of 297 tested) have shown resistance to oseltamivir or zanamivir by enzyme inhibition assay (EIA) and two pandemic (H1N1) 2009 isolates (out of 41 tested) have shown the H275Y mutation known to confer resistance to oseltamivir.
Top of Page
4. International Influenza SurveillanceThe WHO has advised that the world is no longer in phase 6 of influenza pandemic alert, and will now move into the post pandemic period.2 The WHO has reported that as of 1 August 2010 there have been over 18,449 deaths associated with pandemic (H1N1) 2009 influenza worldwide since April 2009. Up to 10 September, WHO has reported that influenza virus transmission is currently most intense in the temperate areas of the Southern Hemisphere and southern Asia.3
- India is still experiencing a country-wide outbreak of pandemic (H1N1) 2009 with active transmission and a substantial number of fatal cases in several states across the country.
- Europe is reporting low influenza activity, with an increasing trend being observed by Estonia, Hungary and Poland.4
- In New Zealand, pandemic (H1N1) 2009 virus transmission has decreased, although activity remains above baseline levels and with significant regional differences. Pandemic (H1N1) 2009 accounted for 91% of all influenza viruses tested from sentinel and non sentinel laboratories. The national ILI consultation rate has decreased in this reporting week, however, is above the seasonal baseline.3
- Chile reported a sharp increase in respiratory disease activity in the last two weeks, with the age groups below 65 years being more affected than the older population. The pandemic (H1N1) 2009 virus has been the most commonly detected influenza virus, although influenza type A/H3N2 and influenza B are circulating at low levels. RSV transmission is also widespread and intense.3
5. Data considerationsThe information in this report is reliant on the surveillance sources available to the Department of Health and Ageing. As access to sources increase and improve, this report will be refined and additional information will be included.
This report aims to increase awareness of pandemic (H1N1) 2009 and seasonal influenza in Australia by providing an analysis of the various surveillance data sources throughout Australia. While every care has been taken in preparing this report, the Commonwealth does not accept liability for any injury or loss or damage arising from the use of, or reliance upon, the content of the report. Delays in the reporting of data may cause data to change retrospectively. For further details about information contained in this report please contact the Influenza Team through email@example.com.
On 17 June 2009 Australia commenced the transition to a new response phase called PROTECT, in which laboratory testing is directed towards people with moderate or severe illness; those more vulnerable to severe illness; and those in institutional settings. This means that the number of confirmed cases does not reflect how many people in the community have acquired pandemic (H1N1) 2009 infection.
Geographic spread of influenza and ILI – Jurisdictional SurveillanceJurisdictions report activity levels (in line with the definitions below) on a fortnightly basis, based on laboratory-confirmed notifications, various syndromic surveillance systems, outbreak reporting and rumour surveillance.
|No activity||No influenza or ILI activity|
|Syndromic only||an increase in syndromic surveillance systems with no laboratory confirmed cases|
|Sporadic||small numbers of laboratory-confirmed influenza cases or a single laboratory-confirmed influenza outbreak during the reporting period, but no increase in cases in syndromic surveillance systems|
|Local||outbreaks of influenza or increases in cases in syndromic surveillance systems and recent laboratory-confirmed influenza in a single region of the state|
|Regional||outbreaks of influenza or increases in cases in syndromic surveillance systems and a recent laboratory confirmed influenza in at least two but less than half the regions of the state|
|Widespread||outbreaks of influenza or increases in cases in syndromic surveillance systems and recent laboratory-confirmed influenza in at least half the regions of the state.|
Sentinel General Practice SurveillanceThe Australian Sentinel Practices Research Network (ASPREN) has Sentinel GPs who report ILI presentation rates in NSW, NT, SA, ACT, VIC, QLD, TAS and WA. As jurisdictions joined ASPREN at different times and the number of GPs reporting has changed over time, the representativeness of ASPREN data in 2010 may be different from that of previous years. ASPREN data and VIDRL influenza surveillance data are sent to the Surveillance Branch on a weekly basis. Further information on Sentinel GPs’ Influenza Surveillance and ASPREN activities are available at www.dmac.adelaide.edu.au/aspren.
Top of Page
Sentinel ED dataWA - ED surveillance data are extracted from the ‘Virus Watch’ Report. This report is provided weekly. The Western Australia Influenza Surveillance Program collects data from eight Perth EDs. NSW - ED surveillance data are extracted from the ‘Weekly Influenza Report, NSW’. The New South Wales Influenza Surveillance Program collects data from 56 EDs across New South Wales.
FluTracking is a project of the University of Newcastle, the Hunter New England Area Health Service and the Hunter Medical Research Institute. FluTracking is an online health surveillance system to detect epidemics of influenza. It involves participants from around Australia completing a simple online weekly survey, which collects data on the rate of ILI symptoms in communities. Data have been provided weekly and have been presented in this report to show the pattern of self reported ILI in the community over the 2009 season.
Further information on FluTracking is available at www.flutracking.net/index.html.
National Health Call Centre NetworkA national organisation provides call centre data for calls relating to ILI or influenza. Data are provided daily and are collated weekly and have been presented in this report to show the pattern of calls to this Call Centre over the 2009 and 2010 season. Data is available for all jurisdictions other than QLD and VIC.
AbsenteeismA national organisation provides data on the number of employees who have been on sick leave for a continuous period of more than three days. These data are not influenza or ILI specific and absenteeism may be a result of other illnesses.
Sentinel Laboratory Surveillance dataLaboratory testing data are provided weekly directly from PathWest (WA), VIDRL (VIC), ICPMR (NSW), sentinel Tasmanian laboratories, and ASPREN (national).
National Notifiable Diseases Surveillance System (NNDSS)Laboratory confirmed influenza (all types) is notifiable in all jurisdictions in Australia. Confirmed cases of influenza are notified through NNDSS by all jurisdictions except NSW. NSW data are sourced from NetEpi.
NetEpiIn 2009, NetEpi, a web-based outbreak case reporting system for pandemic (H1N1) 2009, was used as the primary source of enhanced data on confirmed cases, hospitalisations and ICU admissions in all jurisdictions. In 2010, only data for NSW are sourced from NetEpi.
Analyses of Australian cases are based on the diagnosis date, which is the earliest of the onset date, specimen date or notification date.
Data AnalysisAnalysis of confirmed influenza cases is conducted on combined NetEpi and NNDSS data. Analysis of morbidity (hospitalisations and ICU admissions) and mortality data in 2009 has been conducted on combined NetEpi and QLD hospitalisation data.
FluCANThe Influenza Complications Network (FluCAN) collects detailed clinical information on all hospitalised cases of influenza and pneumonia from a sample of 15 sentinel hospitals across Australia. The data for this reporting period are sourced only from 14 hospitals.
APSUThe Australian Paediatric Surveillance Unit collects clinical information on hospitalised cases of children aged 15 years and under with complications due to influenza infection. Approximately 1300 (80% of total) Paediatric clinicians registered with the Paediatrics and Child Health Division of the Royal College of Physicians, respond to APSU report cards. These report cards seek information regarding hospitalisations relating to 12 diseases or conditions, including influenza.
Top of Page
Australian and New Zealand Intensive Care Society data (ANZICS data)The Australian and New Zealand Intensive Care Society provide data from a `near real time` registry of patients admitted to Australian ICUs. This documents the key factors influencing mortality, as well as the need for hospitalisation and mechanical ventilation. Information collected includes person characteristics and information on relevant co-morbidities, nature of the clinical syndrome associated with pandemic (H1N1) 2009, major therapeutic interventions from which organ failure outcomes can be imputed, vaccination status and vital status at time of ICU discharge and hospital discharge.
WHO Collaborating Centre for Reference & Research on Influenza (WHO CC)Data are provided weekly to the Surveillance Branch from the WHO CC.
Deaths associated with influenza and pneumoniaNationally reported pandemic (H1N1) 2009 deaths are notified by jurisdictions to the Commonwealth Department of Health and Ageing as they occur.
NSW influenza and pneumonia deaths data are collected from the NSW Registry of Births, Deaths and Marriages. Figure 14 is extracted from the ‘Weekly Influenza Report, NSW’
Top of Page
6. References1 NSW Influenza Monthly Epidemiology Report, August 2010. Available from http://www.health.nsw.gov.au/publichealth/infectious/reports/influenza_report_august.asp Accessed 3 September 2010.
2 World Health Organisation virtual press conference, 10 August 2010. Accessed 11 August 2010. Available from http://www.who.int/en/
3 WHO Influenza update – 10 September 2010. Available from http://www.who.int/csr/don/en/ Accessed 17 September 2010.
4 ECDC Surveillance Report – Bi-weekly influenza surveillance overvie 10 September 2010. Available from http://ecdc.europa.eu/en/publications/Publications/100910_SUR_Biweekly_Influenza_Surveillance_Overview.pdf. Accessed on 17 September 2010.